statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction...

Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades

Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo's recent acquisition of...

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Avalo Therapeutics (AVTX) stock price nosedived on Monday after the company published relatively weak financial results. It tumbled by over 23.5% in the pre-market session and reached a low of...

Avalo Therapeutics (AVTX) stock slips after earnings: buy the dip?

Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M...

Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M

Gagnants
Le titre Avalo Therapeutics (NASDAQ:AVTX) a mont vendredi de 289,05% 18,48 dollars lors de la session pre-market.
Le titre Xilio Therapeutics (NASDAQ:XLO) a grimp de 205,16% 1,95...

12 titres de soins de sant  en mouvement lors de la pr -ouverture le 29/03/2024

Titoli in rialzo
Le azioni di Avalo Therapeutics (NASDAQ:AVTX) sono cresciute del 289,05% a 18,48 dollari durante la sessione pre-market di venerd .
Il titolo Xilio Therapeutics (NASDAQ:XLO) salito...

12 titoli sanitari in movimento, pre-market del 29/03/2024

Acquired AVTX-009, Phase-2 ready anti-IL-1 mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment...

Avalo Reports 2023 Financial Results and Provides Business Updates

Gagnants
L'action Avalo Therapeutics (NASDAQ:AVTX) a augment vendredi de 364,84% 22,08 dollars lors de la session ordinaire.
Le titre Nexalin Technology (NASDAQ:NXL) a augment de 83,33% 1,43...

12 titres de soins de sant  en mouvement lors de la session du 29/03/2024

Titoli in rialzo
Il titolo Avalo Therapeutics (NASDAQ:AVTX) ha avuto un aumento del 364,84% a 22,08 dollari durante la sessione regolare di venerd .
Il titolo Nexalin Technology (NASDAQ:NXL) ha...

12 titoli sanitari in movimento, sessione regolare del 29/03/2024

Acciones al alza
Avalo Therapeutics (NASDAQ:AVTX) avanzaron un 364,84% para establecerse en los 22,08 d lares durante la sesi n del regular del viernes.
Nexalin Technology (NASDAQ:NXL) subieron un...

12 acciones de salud en movimiento en la sesi n intrad a del 29/03/2024

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.

Volume	91,720.00
52-Wk High	$1,130.40
52-Wk Low	$3.95

AVTX Avalo Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals